Will angiotensin II receptor antagonists be renoprotective in humans?
Ichikawa
I
I
Vanderbilt University Medical Center, Nashville, Tennessee, USA.
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors / Q000494:pharmacology; D000818:Animals; D003928:Diabetic Nephropathies / Q000188:drug therapy; D005109:Extracellular Matrix / Q000187:drug effects / Q000378:metabolism; D005260:Female; D005919:Glomerular Filtration Rate / Q000187:drug effects; D005922:Glomerulonephritis, IGA / Q000188:drug therapy; D006801:Humans; D007674:Kidney Diseases / Q000517:prevention & control*; D007676:Kidney Failure, Chronic / Q000517:prevention & control; D008875:Middle Aged
D057911:Angiotensin Receptor Antagonists; D000806:Angiotensin-Converting Enzyme Inhibitors